Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Ritchie, AI"'
Background Inhaled corticosteroids (ICS) increase the risk of pneumonia in COPD and are commonly used in patients with COPD-bronchiectasis overlap. Research Question Is the risk of pneumonia associated with ICS further heightened in COPD-bronchiectas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::9ea89a3a3d77621638cafc5c5a83ba33
http://hdl.handle.net/10044/1/105008
http://hdl.handle.net/10044/1/105008
Supplementary oxygen is widely used in critically unwell patients; however, the optimal regime of oxygen therapy is a topic of ongoing debate. Although hypoxemia is dangerous, in vitro evidence suggests that exposing alveolar epithelium to supranorma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::368c9749cce416527e80398eae4c3766
http://hdl.handle.net/10044/1/96734
http://hdl.handle.net/10044/1/96734
Autor:
Ritchie, AI, Brill, SE, Vlies, BH, Finney, LJ, Allinson, JP, Alves-Moreira, L, Wiseman, DJ, Walker, PP, Baker, E, Elkin, SL, Mallia, P, Law, M, Donaldson, GC, Calverley, PMA, Wedzicha, JA
RATIONALE: COPD exacerbations are prone to non-recovery but there are no data about the effectiveness of retreatment on these prolonged events. We examined whether further therapy with ciprofloxacin for incompletely resolved COPD exacerbations prolon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::640ee11d9cecd76607e17c5e6c796a5b
http://hdl.handle.net/10044/1/78157
http://hdl.handle.net/10044/1/78157
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wiseman DJ; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Chelsea and Westminster National Health Service Foundation Trust, London, United Kingdom., Thwaites RS; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Ritchie AI; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Research and Early Clinical Development, Respiratory and Immunology, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Finney L; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Macleod M; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Kamal F; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Shahbakhti H; National Heart and Lung Institute, Imperial College London, London, United Kingdom., van Smoorenburg LH; Department of Pulmonology and Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Kerstjens HAM; Department of Pulmonology and Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Wildenbeest J; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the Netherlands., Öner D; Infectious Diseases Translational Biomarkers, Janssen Pharmaceutica, Beerse, Belgium., Aerssens J; Infectious Diseases Translational Biomarkers, Janssen Pharmaceutica, Beerse, Belgium., Berbers G; Centre of Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, the Netherlands; and., Schepp R; Centre of Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, the Netherlands; and., Uruchurtu A; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Ditz B; Department of Pulmonology and Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Bont L; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the Netherlands., Allinson JP; National Heart and Lung Institute, Imperial College London, London, United Kingdom., van den Berge M; Department of Pulmonology and Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Donaldson GC; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Openshaw PJM; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Wedzicha J; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Publikováno v:
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2024 Oct 15; Vol. 210 (8), pp. 994-1001.
Autor:
Ritchie AI; Imperial College London, Airway Disease Infection, London, United Kingdom of Great Britain and Northern Ireland; a.ritchie@imperial.ac.uk., Hoffman EA; University of Iowa Carver College of Medicine, Radiology, Iowa City, Iowa, United States., Allinson JP; Imperial College London, National Heart and Lung Institute, London, United Kingdom of Great Britain and Northern Ireland., Wedzicha JA; Imperial College London, National Heart and Lung Institute, London, United Kingdom of Great Britain and Northern Ireland.
Publikováno v:
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2024 Aug 30. Date of Electronic Publication: 2024 Aug 30.
Autor:
Ritchie AI; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; AstraZeneca, Cambridge, United Kingdom., Donaldson GC; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Hoffman EA; Department of Radiology and.; Roy J. Carver Department of Biomedical Engineering, Medicine and Biomedical Engineering, University of Iowa, Iowa City, Iowa., Allinson JP; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Royal Brompton Hospital, London, United Kingdom., Bloom CI; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Bolton CE; NIHR Nottingham Biomedical Research Centre.; Centre for Respiratory Research, NIHR Nottingham, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK., Choudhury G; ELEGI and COLT Laboratories, Queen's Medical Research Institute, Edinburgh, United Kingdom., Gerard SE; Roy J. Carver Department of Biomedical Engineering, Medicine and Biomedical Engineering, University of Iowa, Iowa City, Iowa., Guo J; Department of Radiology and., Alves-Moreira L; National Heart and Lung Institute, Imperial College London, London, United Kingdom., McGarvey L; Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, United Kingdom.; Belfast Health and Social Care Trust, Belfast, United Kingdom., Sapey E; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom., Stockley RA; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom., Yip KP; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom., Singh D; Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, United Kingdom., Wilkinson T; Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; National Institute for Health and Care Research Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, United Kingdom., Fageras M; AstraZeneca, Gothenburg, Sweden., Ostridge K; Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; AstraZeneca, Gothenburg, Sweden., Jöns O; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany., Bucchioni E; Chiesi Farmaceutici S.p.A., Parma, Italy., Compton CH; GlaxoSmithKline, Brentford, United Kingdom., Jones P; GlaxoSmithKline, Brentford, United Kingdom., Mezzi K; Novartis Pharma AG, Basel, Switzerland; and., Vestbo J; Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, United Kingdom., Calverley PMA; Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom., Wedzicha JA; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Publikováno v:
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2024 May 15; Vol. 209 (10), pp. 1208-1218.
Autor:
Mah J; National Heart and Lung Institute, Imperial College London, London., Ritchie AI; National Heart and Lung Institute, Imperial College London, London.; Early Clinical Development, Respiratory and Immunology, Clinical, BioPharmaceuticals R&D, AstraZeneca, Cambridge., Finney LJ; National Heart and Lung Institute, Imperial College London, London.; Imperial College Healthcare NHS Trust, UK.
Publikováno v:
Current opinion in pulmonary medicine [Curr Opin Pulm Med] 2024 Mar 01; Vol. 30 (2), pp. 136-140. Date of Electronic Publication: 2023 Dec 15.
Autor:
Ritchie AI; National Heart and Lung Institute, Imperial College London, London, England., Singayagam A; National Heart and Lung Institute, Imperial College London, London, England; Department of Infectious Disease, Imperial College London, London, England., Mitchell S; National Heart and Lung Institute, Imperial College London, London, England., Wedzicha JA; National Heart and Lung Institute, Imperial College London, London, England., Shah A; Department of Infectious Disease Epidemiology, MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, England; Royal Brompton Hospital, Guys and St. Thomas' NHS Foundation Trust, London, England., Bloom CI; National Heart and Lung Institute, Imperial College London, London, England; Imperial College Healthcare NHS Trust, London, England. Electronic address: chloe.bloom06@imperial.ac.uk.
Publikováno v:
Chest [Chest] 2023 Oct; Vol. 164 (4), pp. 875-884. Date of Electronic Publication: 2023 Jun 17.
Autor:
Shah PL; Chelsea & Westminster NHS Foundation Trust, London, UK; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK. Electronic address: pallav.shah@imperial.ac.uk., Orton CM; Chelsea & Westminster NHS Foundation Trust, London, UK; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK., Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil., Donaldson GC; National Heart and Lung Institute, Imperial College London, London, UK., Crabtree Ramírez B; Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City, Mexico., Tonkin J; Chelsea & Westminster NHS Foundation Trust, London, UK; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK., Santos BR; Departamento de Infectología, Hospital Nossa Senhora da Conceição-Grupo Hospitalar Conceição, Porto Alegre, Brazil., Cardoso SW; Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil., Ritchie AI; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK., Conway F; Chelsea & Westminster NHS Foundation Trust, London, UK; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK., Riberio MPD; Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil., Wiseman DJ; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK., Tana A; Chelsea & Westminster NHS Foundation Trust, London, UK; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK., Vijayakumar B; Chelsea & Westminster NHS Foundation Trust, London, UK; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK., Caneja C; Chelsea & Westminster NHS Foundation Trust, London, UK; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK., Leaper C; Chelsea & Westminster NHS Foundation Trust, London, UK., Mann B; Chelsea & Westminster NHS Foundation Trust, London, UK., Samson A; Department of Infection, Hull University Teaching Hospitals NHS Trust, Hull, UK., Bhavsar PK; National Heart and Lung Institute, Imperial College London, London, UK., Boffito M; Chelsea & Westminster NHS Foundation Trust, London, UK; National Heart and Lung Institute, Imperial College London, London, UK., Johnson MR; Chelsea & Westminster NHS Foundation Trust, London, UK., Pozniak A; Chelsea & Westminster NHS Foundation Trust, London, UK; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK., Pelly M; Chelsea & Westminster NHS Foundation Trust, London, UK.
Publikováno v:
The Lancet. Respiratory medicine [Lancet Respir Med] 2023 May; Vol. 11 (5), pp. 415-424. Date of Electronic Publication: 2022 Dec 14.